Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

Scroll down and select country
MEBO TMAU TESTING CURRENTLY SUSPENDED INDEFINITELY

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

London TMAU meeting with Prof Liz Shephard
19th Oct 11am - 1pm
St Mary's Hospital
Praed St, Paddington
London W2 1NY
click to read more
more details : karen.james@meboresearch.org

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Saturday, April 23, 2011

New research paper suggests high TMAO levels associated with heart disease

The more of this by-product, called trimethylamine N-oxide or TMAO, a person or mouse has in the blood, the higher the risk of getting heart disease, the researchers found.

Gut bacteria are actually middlemen in TMAO production. The microbes convert lecithin to a gas that smells like rotten fish. Then an enzyme in the liver changes the foul-smelling gas to TMAO...

...The researchers don’t know exactly which types of gut bacteria make TMAO.

These findings show that the interactions of gut bacteria with diet can influence health, says Rader. The work also suggests that probiotics or drugs might be able to block TMAO production.
2011 Pubmed Abstract : Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

A new research paper suggests that high trimethylamine oxide (TMAO) levels in the blood may be a predictor of heart disease. This is inadvertently of special interest to those with trimethylamninuria because the high TMAO levels will be a result of gut bacterial degradation of choline to trimethylamine (TMA) which is then oxidized by the liver to TMAO. So it may lead to more research into TMAO, particularly into which gut bacteria produce TMA since it currently seems not to be public knowledge as to which species of bacteria produce the TMA. It may also lead to TMAO being more commonly tested. With TMAU, TMAO is probably mostly an issue in secondary TMAU, because in these cases the TMA and TMAO levels are much higher than normal. The authors may not have researched if TMA can be a predictor of heart disease too, because it is not expected to be in high levels in most humans (being converted from TMA to TMAO). In the TMAU community this is unfortunately not the case.

At this stage we can only watch with interest to see how this new lead develops, but hopefully it may indirectly (or directly) lead to more interest and treatment of TMAU.

Links:

Science News : Gut microbes producing trimethylamine oxide may foster heart disease

Eurekalert.org article on subject

Abstract in nature.com
Supplementary information in nature.com

0 comments:

Post a Comment